Capri EGM Build-to-Suit Program Acquires Life Science Real Estate Asset for Company Manufacturing Antibodies for Department of Defense and mRNA for COVID-19 Vaccine
UF startup Ology Bioservices, a wholly owned subsidiary of Resilience, and the operator of the Lab & Research facility, has recently been awarded contract valued as much as $250 million by the Department of Defense for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxins (BoNT).
Clinicians May Now Be Able To Tell COVID-19 From Seasonal Flu With Fast Turnaround Thanks to UF Research
Led by Dr. Z. Hugh Fan, Ph.D., professor at the Herbert Wertheim College of Engineering’s Department of Mechanical and Aerospace Engineering, and Dr. John Lednicky, Research Professor at the College of Public Health and Health Professions’ Department of Environmental and Global Health, an interdisciplinary team at the University of Florida has developed a game-changing diagnostic test for SARS-CoV-2 that is fast, reliable, low-cost and capable of differentiating between COVID-19 and influenza.
UF Health Study Suggests Association Between COVID-19 and Erectile Dysfunction
If the threat of death or severe disability isn’t enough to convince someone to get a COVID-19 vaccination, men can add this possible consequence of coronavirus infection — erectile dysfunction.
Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant
Oragenics, Inc. announced it has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) that will enable Oragenics to pursue an intranasal vaccine designed to protect against the SARS-CoV-2 Omicron variant.
UF Health Researcher’s Analysis Finds New Pattern of Mutations in Omicron Variant
University of Florida Health researcher has successfully analyzed the many mutations in the omicron variant of the SARS-CoV-2 virus, a crucial step in better understanding the variant’s potential threat and ways to combat it.
Patients Who Recover From Severe COVID-19 Still Have Significant Risk of Death, UF Study Finds
Patients who have recovered from severe COVID-19 have more than twice the mortality risk within the year following their illness than people... Read More
COVID-19 Spread Undetected in U.S., Europe Earlier Than Believed, Study Shows, Offering Lessons for Future Outbreaks, Including Transmission of Omicron Variant
Local COVID-19 transmission was underway in California, New York, Florida, and Texas well before the first reported U.S. case in Washington state on Jan. 20, 2020, according to a new study published in Nature, which indicates the virus spread much earlier and faster in the United States and Europe than previously thought.
Oragenics Announces Positive COVID-19 Challenge Study Results Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
UF startup and Sid Martin Biotech alumni company Oragenics, Inc. announced the results from its study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study. The study provided preclinical data for formulations designed for both intranasal and intramuscular administration.
Two Common Compounds Show Effectiveness Against COVID-19 Virus in Early Testing
A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida Health researchers have found.
UF’s COVID Restore Clinic Treats Long Haulers
Dr. Irene Estores, medical director of the Integrative Medicine Program at UF leads the COVID Restore Clinic to treat long haulers. According to the WHO definition, long COVID “occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis.”
